Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Burnout in Caregivers
NCT06617247Phase 1Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in burnout syndrome comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Interpersonal Reactivity Index at 4 weeks, Multifaceted Empathy Test at 4 weeks and 2 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
burnout syndrome
Beyond the preview
Go deeper on NCT06617247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06617247.